Evidence map›Paper›PMID 30814925›Full record

ArticleFrontiers in neuroscience2019

Nucleus Accumbens Shell Orexin-1 Receptors Are Critical Mediators of Binge Intake in Excessive-Drinking Individuals.

Kelly Lei, Claudina Kwok, David Darevsky, Scott A Wegner, JiHwan Yu, Lisa Nakayama, Vincent Pedrozo, Lexy Anderson, Shahbaj Ghotra, Mary Fouad and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neuroscience, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. The role of anterior insula-brainstem projections and alpha-1 noradrenergic receptors for compulsion-like and alcohol-only drinking.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2021
    Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Kelly LeiAlcohol and Addiction Research Group, Department of Neurology, University of California, San Francisco, San Francisco, CA, United States.
Claudina KwokAlcohol and Addiction Research Group, Department of Neurology, University of California, San Francisco, San Francisco, CA, United States.
David DarevskyAlcohol and Addiction Research Group, Department of Neurology, University of California, San Francisco, San Francisco, CA, United States.
Scott A WegnerAlcohol and Addiction Research Group, Department of Neurology, University of California, San Francisco, San Francisco, CA, United States.
JiHwan YuAlcohol and Addiction Research Group, Department of Neurology, University of California, San Francisco, San Francisco, CA, United States.
Lisa NakayamaAlcohol and Addiction Research Group, Department of Neurology, University of California, San Francisco, San Francisco, CA, United States.
Vincent PedrozoAlcohol and Addiction Research Group, Department of Neurology, University of California, San Francisco, San Francisco, CA, United States.
Lexy AndersonAlcohol and Addiction Research Group, Department of Neurology, University of California, San Francisco, San Francisco, CA, United States.
Shahbaj GhotraAlcohol and Addiction Research Group, Department of Neurology, University of California, San Francisco, San Francisco, CA, United States.
Mary FouadAlcohol and Addiction Research Group, Department of Neurology, University of California, San Francisco, San Francisco, CA, United States.
Frederic W HopfAlcohol and Addiction Research Group, Department of Neurology, University of California, San Francisco, San Francisco, CA, United States.
Alcohol Research Group · USUniversity of California, San Francisco · US

Funding

Vector, Transgenic, and Imaging CoreP50AA017072 · NIAAA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI RON, DORIT · 2008 to 2017
$13.9M
NIAAA NIH HHS P50 AA017072
6 · The paper itself

Abstract

Excessive, binge alcohol drinking is a potent and pernicious obstacle to treating alcohol use disorder (AUD), and heavy-drinking humans are responsible for much of the substantial costs and harms of AUD. Thus, identifying key mechanisms that drive intake in higher-drinking individuals may provide important, translationally useful therapeutic interventions. Orexin-1-receptors (Ox1Rs) promote states of high motivation, and studies with systemic Ox1R inhibition suggest a particular role in individuals with higher intake levels. However, little has been known about circuits where Ox1Rs promote pathological intake, especially excessive alcohol consumption. We previously discovered that binge alcohol drinking requires Ox1Rs in medial nucleus accumbens shell (Shell), using two-bottle-choice Drinking-in-the-Dark (2bc-DID) in adult, male C57BL/6 mice. Here, we show that Shell Ox1Rs promoted intake during intermittent-access alcohol drinking as well as 2bc-DID, and that Shell inhibition with muscimol/baclofen also suppressed 2bc-DID intake. Importantly, with this large data set, we were able to demonstrate that Shell Ox1Rs and overall activity were particularly important for driving alcohol consumption in higher-drinking individuals, with little overall impact in moderate drinkers. Shell inhibition results were compared with control data combined from drug treatments that did not reduce intake, including NMDAR or PKC inhibition in Shell, Ox1R inhibition in accumbens core, and systemic inhibition of dopamine-1 receptors; these were used to understand whether more specific Shell Ox1R contributions in higher drinkers might simply result from intrinsic variability in mouse drinking. Ineffectiveness of Shell inhibition in moderate-drinkers was not due to a floor effect, since systemic baclofen reduced alcohol drinking regardless of basal intake levels, without altering concurrent water intake or saccharin consumption. Finally, alcohol intake in the first exposure predicted consumption levels weeks later, suggesting that intake level may be a stable trait in each individual. Together, our studies indicate that Shell Ox1Rs are critical mediators of binge alcohol intake in higher-drinking individuals, with little net contribution to alcohol drinking in more moderate bingers, and that targeting Ox1Rs may substantially reduce AUD-related harms.

Indexed as

alcoholbingeexcessive drinkersnucleus accumbensorexinSB-334867shell

Identifiers

PMID30814925
PMCPMC6381036
OpenAlexW2914511485

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.